U Mass Chan Medical School

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Multiple myeloma1 trial
• Vitiligo1 trial

Phase

• Phase 22 trials

Status

• Active, not recruiting1 trial
• Withdrawn1 trial

Lead sponsor

• Elixiron Immunotherapeutics (Hong Kong) Ltd.1 trial
• GeoVax, Inc.1 trial

Running trials

• Active, not recruiting

  SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

  NCT04977024· Phase 2· GeoVax, Inc.· Source

Closed trials

• Recruiting

  Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

  NCT07223229· Phase 2· Elixiron Immunotherapeutics (Hong Kong) Ltd.· Source